RxY
Tim Dungey is an experienced research professional with a strong background in client service and project delivery. Tim currently serves as the Research Director at RxY since January 2022. Prior roles include Client Service Director at M3 Global Research from November 2018 to April 2021, and Account Director at Sermo WorldOne from July 2014 to October 2018. Tim also held the position of Research Director at Instar Research between January 2013 and June 2014, and served as Director of Project Delivery and Client Service Manager at Medefield from January 2007 to December 2012. Tim's career began as a Fieldwork Executive at GfK Healthcare from May 2005 to December 2006.
This person is not in any teams
This person is not in any offices
RxY
RxY (part of the P/S/L Group) is a Global Healthcare Research business focused on understanding the real reasons behind treatment selection. Founded in 2018, RxY is dedicated to helping our clients understand which therapies are considered for a patient, what drives the actual treatment decision, and why therapies were not considered. Focusing on “in-play” patients, i.e., newly-initiating or switching, RxY provides unique insights and recommendations to drive clients’ patient share. RxY utilizes AI and chatbot technology to deliver precise understanding of “in the moment” decision making by physicians. Via our analytics teams, RxY provides deep analysis supporting: senior executives, competitor intelligence, brand & insights teams. Deliverables include, but are not limited to: reports, presentations, workshops, and dashboards. To discuss how RxY can address your unmet, business-critical needs, please contact: paul.oshaughnessy@rxyhc.com